Essex Woodlands Healthcare Partners

Grundium Oy announced the acquisition of Visiopharm A/S, combining digital slide scanning with AI-driven precision pathology software.

Ascend-ABL announced Seiga Ohmine as chief commercial officer, Sharad Dubey as chief financial officer, and Patrick Lansky as senior vice president of global business development.

The acquisition expands EUSA Pharma’s presence in oncology and rare diseases. SYLVANT is the only FDA- and EMA-approved treatment for idiopathic multicentric Castleman’s disease (iMCD).

EW Healthcare Partners appointed Andy Thomson as an operating partner; he has more than three decades of commercial and leadership experience.

Andy Thomson joined EW as an Operating Partner in 2025. Mr. Thomson brings to EW decades of experience, most recently as Senior Vice President and President, Europe, Middle East and Africa, Corporate Accounts and Marketing of Thermo Fisher Scientific.

Evis Hursever joined EW in 2011 and became Managing Director in 2019.

Guido Neels joined EW in 2006 and transitioned to an Operating Partner in 2013.

Petri Vainio joined EW as Managing Director in 2004 and has been leading the EW growth equity investment practice since then. He serves as the Chairman of the Firm’s Executive Committee.

Discover EW Healthcare Partners, a growth equity firm dedicated to driving positive impact in healthcare and patient care services in the US and Europe.

The company has three office locations for partnership inquiries and contacts with specific team members.

The company is a healthcare growth equity firm that supports companies in the US and Europe.

The privacy notice explains how the company collects and uses personal data and how individuals can exercise their rights under applicable data protection laws.